. Author manuscript; available in PMC: 2020 May 1.

Published in final edited form as: J Acquir Immune Defic Syndr. 2019 May 1;81(1):36–43. doi: 10.1097/QAI.0000000000001988

Table 3.

Distribution of MP-TF, by subclinical cardiovascular disease¹ case status (N=275)

Characteristic	Control (sCVD-), N=177	Case (sCVD+), N=98	p-value²
Characteristic	N (%) or median (IQR)	N (%) or median (IQR)	p-value²
MP-TF activity (pg/mL)	0.10 (0.05–0.19)	0.10 (0.05–0.27)	0.59
MP-TF activity, >0.500 pg/mL	9 (5)	14 (14)	0.02
MP-TF activity, >0.537 pg/mL	6 (3)	13 (13)	0.01

Subclinical CVD was defined based on focal plaque assessed using B mode ultrasound of the carotid artery.

p-value for Wilcoxon Rank-sum test or Chi-Square test